PHAR
Pharming GroupBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PHAR vs peer average
66/100
PHAR vs. peer average (B vs. C)
Grade spread
A 2 · B 1 · C 3 · D 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Same-sector, similar-size biotech candidate; useful mainly for small-cap catalyst and balance-sheet-risk comparison, while therapeutic overlap is not established by the packet.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PHAR
Pharming Group
ABUS
Arbutus Biopharma
Grade
B
B
Momentum
65
64
Value
62
56
Sentiment
66
70
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ABUS
PHAR / ABUS
Grade Position
In line
PHAR vs. peer average (B vs. C)
66/100
Momentum
65
PHARValue
62
PHARSentiment
66
ABUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PHAR
ABUS is the first peer returned for this comparison set.